Live Quote · NASDAQACRVHealthcare· Biotechnology

Acrivon Therapeutics, Inc. Common Stock

$1.15▼ 17.86%($-0.25)
MKT CAP $49.35MNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
90
Valuation
20
Profitability
30
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACRV research report →

Analyst Price Target
$21.83+1798.3% vs. today

Range $17 – $30

Analyst RatingBuy
9 Buy1 Hold0 Sell

Price Chart

-49.12% · this period
$3.01$2.08$1.15Nov 20May 26Nov 20
52-Week Range7% of range
Low
$0.97
Current
$1.15
High
$3.56